More guidance is expected from the US FDA in the coming months to help combination product sponsors avoid mistakes in their requests for designation and reverse a low filing rate.
Nearly 87% of the designation requests received in fiscal year 2017 were not filed or withdrawn because of missing information...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?